Clinical Trial Matcher

NCT07847099

Platelet Indices and Blood Groups in Type 2 Diabetes Vascular Complications

Not Yet Recruiting · Not specified · Assiut University · registry updated 2026-09-29

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

This cross-sectional study aims to evaluate the association of platelet indices and ABO blood groups with vascular complications in patients with type 2 diabetes mellitus.

Inclusion

  • Age 18 years or older
  • Confirmed diagnosis of type 2 diabetes mellitus according to ADA criteria
  • Written informed consent

Exclusion

  • Type 1 diabetes mellitus
  • Gestational diabetes
  • Acute infection or sepsis
  • Hematological disorders affecting platelet count or function
  • Chronic liver disease
  • Autoimmune diseases

Open NCT07847099 on ClinicalTrials.govAll conditions